EQUBITS Licenses Foresight to Novartis and Johnson and Johnson
News Nov 01, 2005
EQUBITS have announced the first customers of their flagship product, EQUBITS Foresight. Customers include Novartis, Johnson and Johnson PRD, and BASF.
"After extensive testing and validation, customers are purchasing EQUBITS Foresight as an easy-to-use software solution for their data mining problems. Our customers expect a lot from new software and, as a result, evaluated and tested Equbits Foresight rigorously. By outperforming existing methods in customer evaluations, EQUBITS has established itself as a best in class, accurate, interpretable predictive modeling solution provider," says Ravi Mallela, VP of Marketing, EQUBITS LLC.
EQUBITS Foresight is being used to solve complex predictive modeling problems in the High Throughput Screening and ADME-Tox environments.
By applying EQUBITS Foresight to challenging predictive modeling problems, customers are generating more accurate, interpretable results.
"Equbits provides customers with data mining solutions that combine the accuracy of non-linear modeling with a level of interpretability provided by linear models," says Dr. Mallela.
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Chili Pepper Derived Anti-Obesity Drug Shows Promise in Animal TrialsNews
A novel drug based on capsaicin, the compound that gives chili peppers their spicy burn, caused long term weight loss and improved metabolic health in mice eating a high fat diet.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019